All generics articles – Page 4
-
Business
Objections raised to GSK pay-for-delay deals
The UK Office of Fair Trading believes deals to delay generic drugs infringed competition laws
-
Business
$595m octreotide deal grabs Roche
Company will get worldwide rights to oral formulation of growth hormone drug
-
Business
GSK expands in India and Nigeria
Company has struck deals to increase ownership of subsidiaries
-
Business
Patent woes lead to sharp sales losses
Bristol-Myers Squibb, AstraZeneca and Eli Lilly have all suffered loss of exclusivity for key drugs
-
Business
Teva pulls generic antidepressant
FDA rules that Budeprion XL is not equivalent to Wellbutrin XL
-
OpinionMonopoly money
Dean Baker says it’s time to start talking seriously about the way in which pharma is funded
-
Business
Generic Actos approved
Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets
-
NewsFree generics for India's poor but big pharma misses out
India’s healthcare plans will see a massive expansion in the use of generic drugs at the expense of branded medicines
-
News
China targets patented drugs with law change
Domestic drug companies can apply for licences to produce patented drugs when public health overrides intellectual property considerations
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Next Page